Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Nina Massey

Study finds yet another use for popular diabetes and obesity drugs

Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk, - (PA)

Popular obesity drugs, such as Ozempic, could also help to protect the kidneys, a new study has suggested.

The findings indicate the medications might reduce the risk of kidney deterioration and failure, regardless of whether or not somebody has diabetes.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.